Simris Group AB is a Sweden-based company primarily engaged in the special foods and wellbeing products industry. The Company operates as a manufacturer of dietary supplements as well as specialty foods. The Company's products are based on algae-plants that live in water, such as strains of cyanobacteria. These products are rich of Omega-3 oils produced by microalgae on dry land and made from natural ingredients. The Company scope of activity includes development of technologies and processes for cultivation and production with microalgae, consulting and marketing in manufacturing, technology as well as environmental services with microalgae. The Company's technology provides access to bioactive substances while replacing unsustainable raw materials from endangered marine species and ecosystems.

Employees

Sector

Food Processing

Calendar

12/08 Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
06/08/26	SEK 0.1135	+10.19%	140,309
04/08/26	SEK 0.1030	-10.04%	74,042
03/08/26	SEK 0.1145	-0.43%	76,904
31/07/26	SEK 0.1150	-10.51%	153,115
30/07/26	SEK 0.1285	-0.77%	282,820

Delayed Quote Nasdaq Stockholm

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Nasdaq Stockholm Other stock markets 02:00:00 06/08/26 am AEST			5-day change	1st Jan Change
0.1135 ^SEK	+10.19%		-12.36%	+165.19%

15/07	Simris Group AB Announce Appointment of Andreas Pahl as Chief Executive Officer of Simris Biologics GmbH, Effective July 15, 2026	CI
13/05	Simris Group AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	139M 14.57M 12.65M 11.79M 10.83M 20.49M 1.39B 20.71M 54.35M 693M 54.7M 53.5M 2.29B	P/E 2024	-0.77x	P/E 2025	-1.01x
Enterprise Value	140M 14.68M 12.75M 11.89M 10.92M 20.65M 1.4B 20.88M 54.78M 698M 55.13M 53.92M 2.31B	EV / Sales 2024	9.21x	EV / Sales 2025	17.2x
Free-Float	92.76%	Yield 2024 *	-	Yield 2025	-

15/07	Simris Group AB Announce Appointment of Andreas Pahl as Chief Executive Officer of Simris Biologics GmbH, Effective July 15, 2026	CI
13/05	Simris Group AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
12/05	Simris Group advances asset divestment process with two prospective buyers	RE
12/05	An undisclosed buyer entered into a Memorandum of Understanding to acquire Microalgae production in Hammenhög, Sweden of Simris Group AB from Simris Group AB (OM:SIMRIS B).	CI
15/04	Simris Group AB Auditor Raises 'Going Concern' Doubt	CI
20/03	Simris evaluating options to expand its ADC-payload development programme	RE
11/03	Simris updates on divestment of its assets	RE
02/03	Simris Q4 EBIT loss narrows to SEK 8.4 million	RE
01/03	Simris Group AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
20/01	Simris Group AB Appoints Julian Read as a New Member of the Board	CI
20/01	Simris enters into MOU regarding divestment of assets in Hammenhög	RE
19/01	Immunrise Biocontrol France SAS entered into a Memorandum of Understanding to acquire Microalgae production in Hammenhög, Sweden of Simris Group AB (OM:SIMRIS B).	CI
29/11	Simris Group enters into bridge loan agreement	RE

13/07	Simris : A holder of warrants in Simris Group AB (publ) has declared his intention to exercise 3.3 million warrants amounting to total proceeds of EUR 15,000	PU
25/06	Simris : Bulletin from Simris Group AB’s annual general meeting	PU
28/02	Simris : Year-end Report Q4 2025	PU
29/11	Simris : enters into bridge loan agreement	PU
12/11	Simris : Interim Report Q3 2025	PU

Simris Group AB Stock

Stocks

SIMRIS B

SE0008091664

Food Processing

Valuation: Simris Group AB

Chart: Simris Group AB

Latest news : Simris Group AB

Press Releases: Simris Group AB

Quotes and Performance

Course Extremes

Managers and Directors: Simris Group AB

Special Foods & Wellbeing Products

Financials

Company Profile

Quotes

Income Statement and Estimates

1 day	+10.19%
1 week	-12.36%
Current month	-1.30%
1 month	+28.39%
3 months	+22.31%
6 months	-11.67%
Current year	+165.19%

1 week	0.1	0.14
1 month	0.07	0.17
Current year	0.04	0.2
1 year	0.04	0.21
3 years	0.03	0.35
5 years	0.03	1.58
10 years	0.03	24.5

Manager	Title	Age	Since
Daniel Kubitza CEO	Chief Executive Officer	-	10/11/2025
Christoffer Tell CEO	Chief Executive Officer	39	17/09/2021
Heike Enke PRN	Corporate Officer/Principal	51	-

Director	Title	Age	Since
Magnus Högström BRD	Director/Board Member	53	19/12/2019
Frank Puccio BRD	Director/Board Member	70	07/05/2021
Jonathan Royce CHM	Chairman	50	18/10/2024

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SIMRIS GROUP AB	+10.19%	-12.36%	-31.21%	-57.81%	14.57M
ZHEJIANG NHU COMPANY LTD.	-1.03%	+2.09%	+34.66%	+81.82%	13.69B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+1.71%	-2.31%	-26.18%	+268.63%	7.71B
BYHEALTH CO., LTD	+0.49%	+4.25%	-12.71%	-51.32%	2.54B
BELLRING BRANDS, INC.	-0.12%	-4.48%	-64.91%	-65.25%	1.48B
HERBALIFE LTD.	+0.35%	+1.88%	+34.73%	-31.11%	1.33B
XIAMEN KINGDOMWAY GROUP COMPANY	-1.12%	+5.44%	-29.30%	-25.97%	1.29B
JAMIESON WELLNESS INC.	-0.55%	-1.71%	+20.71%	+51.41%	1.23B
TSI GROUP CO., LTD.	+0.73%	+0.10%	-36.07%	-	1.14B
THE SIMPLY GOOD FOODS COMPANY	-0.49%	+9.95%	-62.46%	-70.99%	1B
Average	+1.02%	-0.05%	-17.27%	+11.05%	3.14B
Weighted average by Cap.	-0.03%	+0.44%	+2.35%	+95.08%

	2024	2025
Net sales	2.89M 303K 263K 245K 225K 426K 28.8M 431K 1.13M 14.4M 1.14M 1.11M 47.71M	1.62M 169K 147K 137K 126K 238K 16.1M 241K 631K 8.05M 635K 621K 26.66M
Net income	-34.6M -3.63M -3.15M -2.94M -2.7M -5.1M -345M -5.16M -13.53M -172M -13.62M -13.32M -571M	-26.81M -2.81M -2.44M -2.27M -2.09M -3.95M -267M -3.99M -10.48M -134M -10.55M -10.32M -443M
Net Debt	93K 9.74K 8.46K 7.89K 7.25K 13.71K 927K 13.86K 36.36K 463K 36.59K 35.79K 1.54M	1.09M 115K 99.43K 92.71K 85.17K 161K 10.89M 163K 427K 5.45M 430K 421K 18.04M